BLOG

Thursday, January 7, 2021

Sun Pharma rises 3%, hits over 2-year high on steady earnings visibility

The board of directors of Sun Pharma are scheduled to meet on January 29, 2021 to consider and approve Q3 results

from Home Page https://ift.tt/3pZQqh8
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...